Log in
Enquire now
‌

US Patent 7314887 Thrombopoietin activity modulating compounds and methods

Patent 7314887 was granted and assigned to Ligand Pharmaceuticals on January, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Ligand Pharmaceuticals
Ligand Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7314887
Patent Inventor Names
E. Adam Kallel0
Jackline E. Dalgard0
Jyun-Hung Chen0
Lin Zhi0
Matthew H. McNeill0
Thomas Lau0
Richard J. Penuliar0
Todd A. Miller0
...
Date of Patent
January 1, 2008
Patent Application Number
11256572
Date Filed
October 21, 2005
Patent Primary Examiner
‌
Rebecca Anderson
Patent abstract

Disclosed herein are compounds of Formula (I), (II), and (III)

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7314887 Thrombopoietin activity modulating compounds and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.